Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?

You are concerned about the escalating use of antibiotics in your intensive care unit (ICU). This has put a strain on the ICU budget and is possibly resulting in the emergence of resistant bacteria. You review the situation with your team and one suggestion is to consider using biomarkers such as pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehabi, Yahya, Seppelt, Ian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481434/
https://www.ncbi.nlm.nih.gov/pubmed/18466649
http://dx.doi.org/10.1186/cc6860
_version_ 1782157990592249856
author Shehabi, Yahya
Seppelt, Ian
author_facet Shehabi, Yahya
Seppelt, Ian
author_sort Shehabi, Yahya
collection PubMed
description You are concerned about the escalating use of antibiotics in your intensive care unit (ICU). This has put a strain on the ICU budget and is possibly resulting in the emergence of resistant bacteria. You review the situation with your team and one suggestion is to consider using biomarkers such as procalcitonin to better guide appropriate antibiotic decision making.
format Text
id pubmed-2481434
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24814342008-07-24 Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Shehabi, Yahya Seppelt, Ian Crit Care Review You are concerned about the escalating use of antibiotics in your intensive care unit (ICU). This has put a strain on the ICU budget and is possibly resulting in the emergence of resistant bacteria. You review the situation with your team and one suggestion is to consider using biomarkers such as procalcitonin to better guide appropriate antibiotic decision making. BioMed Central 2008 2008-05-02 /pmc/articles/PMC2481434/ /pubmed/18466649 http://dx.doi.org/10.1186/cc6860 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Review
Shehabi, Yahya
Seppelt, Ian
Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
title Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
title_full Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
title_fullStr Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
title_full_unstemmed Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
title_short Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
title_sort pro/con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481434/
https://www.ncbi.nlm.nih.gov/pubmed/18466649
http://dx.doi.org/10.1186/cc6860
work_keys_str_mv AT shehabiyahya procondebateisprocalcitoninusefulforguidingantibioticdecisionmakingincriticallyillpatients
AT seppeltian procondebateisprocalcitoninusefulforguidingantibioticdecisionmakingincriticallyillpatients

Ejemplares similares